Archive | 2021
Preclinical models in oncological pharmacology: limits and advantages
Abstract
1Department of Pharmacy, School of Medicine and Surgery, Federico II University of Naples, Naples, Italy 2Department of Life Sciences, University of Trieste, Trieste, Italy 3NEST, Istituto Nanoscienze-CNR and Scuola Normale Superiore, Pisa, Italy 4Department of Life Sciences, University of Siena, Siena, Italy 5Department of Biological, Chemical and Pharmaceutical Science and Technology, University of Palermo, Palermo, Italy 6Department of Drug Science and Technology, University of Torino, Torino, Italy 7Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Catholic University Medical School, Rome, Italy 8Gruppo di Farmacologia Oncologica, Società Italiana di Farmacologia (SIF), Italy